These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33609645)

  • 1. The association of Chlamydia pneumoniae infection with atherosclerosis: Review and update of in vitro and animal studies.
    Khoshbayan A; Taheri F; Moghadam MT; Chegini Z; Shariati A
    Microb Pathog; 2021 May; 154():104803. PubMed ID: 33609645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immune response associated with Chlamydia pneumoniae infection in atherosclerotic patients.
    El Yazouli L; Seghrouchni F; Hejaji H; Bouazza M; Alami AA; Dakka N; Radouani F
    Microb Pathog; 2020 Feb; 139():103860. PubMed ID: 31707079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis.
    Yavuz MT; Yavuz O; Yazici M; Guler S; Ozhan H; Albayrak S; Coskun A
    Scand J Clin Lab Invest; 2006; 66(6):523-34. PubMed ID: 17000560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia pneumoniae infections augment atherosclerotic lesion formation: a role for serum amyloid P.
    Ezzahiri R; Stassen FR; Kurvers HR; Dolmans V; Kitslaar PJ; Bruggeman CA
    APMIS; 2006 Feb; 114(2):117-26. PubMed ID: 16519748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of Chlamydia pneumoniae and human cytomegalovirus infection in patients with chronic peripheral vascular disease and their relation to inflammation, endothelial dysfunction and changes in lipid metabolism.
    Kraml PJ; Roubalová K; Bulvas M; Sommerová Z; PotoCková J; Mandys V; Andel M
    Folia Microbiol (Praha); 2008; 53(6):551-7. PubMed ID: 19381484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Infection of Chlamydia Pneumoniae.
    Ma Y; Sun J; Che G; Cheng H
    Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Murine Norovirus on Chlamydia pneumoniae-Accelerated Atherosclerosis in ApoE(-/-) Mice.
    Patil K; Campbell LA; Rosenfeld ME; Paik J; Brabb T; O'brien KD; Maggio-Price L; Hsu CC
    Comp Med; 2016; 66(3):188-96. PubMed ID: 27298243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis.
    Deniset JF; Pierce GN
    Fundam Clin Pharmacol; 2010 Oct; 24(5):607-17. PubMed ID: 20653790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR2/CXCR4 coassociation facilitates
    Miao G; Zhao X; Wang B; Zhang L; Wang G; Zheng N; Liu J; Xu Z; Zhang L
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1420-H1435. PubMed ID: 32330088
    [No Abstract]   [Full Text] [Related]  

  • 10. Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease.
    Droemann D; Rupp J; Goldmann T; Uhlig U; Branscheid D; Vollmer E; Kujath P; Zabel P; Dalhoff K
    Am J Respir Crit Care Med; 2007 Apr; 175(8):791-7. PubMed ID: 17290045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor receptor superfamily members 1a and 1b contribute to exacerbation of atherosclerosis by Chlamydia pneumoniae in mice.
    Zafiratos MT; Cottrell JT; Manam S; Henderson KK; Ramsey KH; Murthy AK
    Microbes Infect; 2019 Mar; 21(2):104-108. PubMed ID: 30292879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells.
    Oksaharju A; Lappalainen J; Tuomainen AM; Pussinen PJ; Puolakkainen M; Kovanen PT; Lindstedt KA
    J Cell Mol Med; 2009 Jan; 13(1):103-13. PubMed ID: 18298659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic perivascular inoculation with Chlamydophila pneumoniae results in plaque formation in vivo.
    Engelmann MG; Redl CV; Pelisek J; Barz C; Heesemann J; Nikol S
    Lab Invest; 2006 May; 86(5):467-76. PubMed ID: 16550192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae accelerates coronary artery disease progression in transgenic hyperlipidemia-genetic hypertension rat model.
    Herrera VL; Shen L; Lopez LV; Didishvili T; Zhang YX; Ruiz-Opazo N
    Mol Med; 2003; 9(5-8):135-42. PubMed ID: 14571321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher prevalence of Chlamydia pneumoniae seropositivity in Finnish twins compared with co-twins living in Sweden: relationships with markers of subclinical atherosclerosis.
    Jartti L; Raitakari OT; Järvisalo MJ; Hammar N; Kaprio J; Koskenvuo M; Marniemi J; Saikku P; Rönnemaa T
    Clin Sci (Lond); 2003 Sep; 105(3):303-13. PubMed ID: 12747799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of secondhand cigarette smoke and Chlamydia pneumoniae accelerates atherosclerosis.
    Zhao X; Bu DX; Hayfron K; Pinkerton KE; Bevins CL; Lichtman A; Wiedeman J
    Atherosclerosis; 2012 May; 222(1):59-66. PubMed ID: 22410122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic signs for the inflammatory role of Chlamydia pneumoniae in the high-grade atherosclerotic coronary artery wall.
    Legan M; Vraspir-Porenta O; Kese D; Zorc-Pleskovic R; Zorc M
    Angiology; 2004; 55(5):525-31. PubMed ID: 15378115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Signs of active infection with Chlamydia pneumoniae in patients with coronary heart disease].
    Hrubá D; Roubalová K; Kraml P; Andĕl M
    Cas Lek Cesk; 2004; 143(12):830-5. PubMed ID: 15730214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pivotal Pathogenic and Biomarker Role of Chlamydia Pneumoniae in Neurovascular Diseases.
    Richard SA
    Curr Neurovasc Res; 2018; 15(3):262-273. PubMed ID: 30019645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development.
    Xia M; Chen D; Endresz V; Faludi I; Szabo A; Gonczol E; Kakkar V; Lu X
    PLoS One; 2013; 8(12):e81056. PubMed ID: 24349031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.